David Bautz
Analyst-Equity bei Zacks Investment Research, Inc. (Small Cap Research)
Profil
Dr. David Bautz is a Senior Biotechnology Analyst at Zacks Investment Research, Inc. He joined the firm in February 2014.
Dr. Bautz worked for two years as a Research Associate at Human Genome Sciences, Inc., a biotechnology company that was eventually acquired by GlaxoSmithKline.
He obtained his PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill in 2008.
His dissertation research focused on the characterization of autoantibodies in patients suffering from an orphan autoimmune disease.
He obtained his BS and MS degrees in Biochemistry from Virginia Tech.
Aktive Positionen von David Bautz
| Unternehmen | Position | Beginn |
|---|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Analyst-Equity | 01.02.2014 |
Ausbildung von David Bautz
| The University of North Carolina at Chapel Hill | Doctorate Degree |
| Virginia Polytechnic Institute & State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Finance |
